Bladder Carcinoma Recruiting Phase 2 / 3 Trials for DB00996 (Gabapentin)

Also known as: Urinary bladder carcinoma / Carcinoma urinary bladder / Carcinoma of bladder / Bladder carcinoma NOS / Carcinoma bladder / Bladder neoplasms malignant / Malignant neoplasm of bladder / Bladder cancer / Urinary Bladder Cancer / Malignant neoplasm of bladder, part unspecified / Bladder cancer NOS / Ca bladder

IndicationStatusPhase
DBCOND0036971 (Bladder Carcinoma)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02355886Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical CystectomySupportive Care